United States · Federal contract register · Supplier record

HEMOGLOBIN OXYGEN THERAPEUTICS LLC

Line: Health r&d services; health care services; experimental development (AN13)Register loaded to September 2026Compiled 17 October 2026

HEMOGLOBIN OXYGEN THERAPEUTICS LLC — United States · Federal contract register · Supplier record: 2 contracts, all years ($9,670,708 · Aug 2016 – May 2025); $9.6M since January 2024 (1 contract · 1 agency); 12th rank in the line (of 102 suppliers · 1.69%); 3 agencies never served ($516M on the line without HEMOGLOBIN OXYGEN THERAPEUTICS LLC).

Assay record ASY-US-153986J020 · Cite as: Assay Systems, “HEMOGLOBIN OXYGEN THERAPEUTICS LLC: 1 government contract in the United States since 2024”, https://assay-systems.com/register/us/hemoglobin-oxygen-therapeutics-llc/

2
contracts, all years
$9,670,708 · Aug 2016 – May 2025
$9.6M
since January 2024
1 contract · 1 agency
12th
rank in the line
of 102 suppliers · 1.69%
3
agencies never served
$516M on the line without HEMOGLOBIN OXYGEN THERAPEUTICS LLC

Own record by year

2025 onward
$9.6M
20252026

Who buys from HEMOGLOBIN OXYGEN THERAPEUTICS LLC

since January 2024
1agencies
$9.6Mpaid
100.0%top buyer
Department of Defense100.0%
$9,559,948

Won without a rival

2025-05-22 – 2025-05-22
1uncontested awards
100%of its awards
1without a competition
0single bid

HEMOGLOBIN OXYGEN THERAPEUTICS LLC won 1 of its 1 public contract awards in United States without a rival from 2025-05-22 to 2025-05-22, worth $9.6M: 1 without a competition and 0 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Defense Health Agency with 1.

Buyers: Defense Health Agency (1)

Every uncontested award of HEMOGLOBIN OXYGEN THERAPEUTICS LLC · United States: all uncontested awards

The line

since January 2024
$566Mline value
124contracts
4agencies
102suppliers
70.3%held by top ten

Health r&d services; health care services; experimental development (AN13)

$239M
$109M
$218M
202420252026Jan–Sep
12thof 102 suppliers
$9,559,948HEMOGLOBIN OXYGEN THERAPEUTICS LLC in the line
1.69%share of the line
18.9%of $50,693,667 spent by Department of Defense

Agencies that buy the line and never bought from HEMOGLOBIN OXYGEN THERAPEUTICS LLC

3agencies
106contracts
$515,561,760since January 2024
Department of Health and Human Services63 contracts
$485,502,671
Department of the Interior17 contracts
$26,151,140
Department of Veterans Affairs26 contracts
$3,907,948

How the line is bought

by value, since 2024
1%no competition
70%one applicant
0of these to HEMOGLOBIN OXYGEN THERAPEUTICS LLC
Competed, one supplier applied41 contracts
$393,556,081 · 69.5%
Competed, several suppliers applied54 contracts
$164,707,528 · 29.1%
Awarded directly, no competition29 contracts
$7,991,818 · 1.4%

Contracts reaching their end dates

Oct 2026 – October 2027
34contracts
$69,076,959end by October 2027
10end in September 2027 · $35.6M
31in agencies never served · $46.9M
$750K
$1.8M
$69.8K
$1.4M
$1.5M
$13.1M
$186K
$2.0M
$12.6M
$35.6M
Oct 261 contractNov 263 contractsDec 261 contractJan 271 contractFeb 273 contractsMar 2710 contractsMay 271 contractJun 271 contractAug 273 contractsSep 2710 contracts

Suppliers next to it in the line

since January 2024
OREXO US INC1 contract · 1 agency
$11,450,712
HEMOGLOBIN OXYGEN THERAPEUTICS LLC
$9,559,948
REVVITY HEALTH SCIENCES, INC.1 contract · 1 agency
$9,263,365
UNIVERSITY OF CALIFORNIA, LOS ANGELES1 contract · 1 agency
$9,188,827

All 102 suppliers in the line

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.